SARS-CoV2: Clinical Trials

5 trials for SARS-CoV2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5
Phase 33Terminated 3

Follow SARS-CoV2: new trials by email Literature Review of SARS-CoV2 trials Research Report on SARS-CoV2

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients
BIO101, Placebo - Covid-19, SARS-CoV2
Phase 2 / Phase 3TerminatedBiophytis2382020-08-262026-08-12
Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
Janus Kinase Inhibitor (ruxolitinib), Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2
Phase 2 / Phase 3TerminatedVanderson Geraldo Rocha52020-08-142021-04-08
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
Hyperbaric oxygen - SARS (Severe Acute Respiratory Syndrome), Cytokine Storm
Phase 2 / Phase 3TerminatedKarolinska Institutet342020-06-032023-01-09
Novel Agents for Treatment of High-risk COVID-19 Positive Patients
Ivermectin, Camostat Mesilate, Artemesia annua - COVID, Sars-CoV2
Phase 2TerminatedSusanne Arnold132020-05-012022-01-20
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
BMS-986253 - Solid Tumor, Sars-CoV2
Phase 2TerminatedColumbia University432020-04-162025-05-22

Narrower conditions

COVID-19 (3)  ·  Coronavirus Infections (1)  ·  Cytokine Release Syndrome (1)  ·  Hematologic Neoplasms (1)  ·  Respiratory Distress Syndrome (1)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Coronaviridae Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Coronavirus Infections (2)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Inflammation (1)  ·  Neoplasms (1)

Interventions

Artesunate (1)  ·  HuMax-IL8 (1)  ·  Hyperbaric Oxygenation (1)  ·  Ivermectin (1)  ·  Janus Kinase Inhibitors (1)  ·  camostat (1)  ·  ruxolitinib (1)

Sponsors

Biophytis (1)  ·  Columbia University (1)  ·  Karolinska Institutet (1)  ·  Susanne Arnold (1)  ·  Vanderson Geraldo Rocha (1)

Countries

United States (3)  ·  Brazil (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  Sweden (1)

Top investigators

Anders Kjellberg, MD (1)  ·  Capucine Morelot-Panzini, MD (1)  ·  Kenny Rodriguez-Wallberg, MD, PhD (1)  ·  Mark N Stein, MD (1)  ·  Peter Lindholm, MD, PhD (1)  ·  Susanne Arnold, MD (1)

Results publications

PMID 33430924, PMID 34226219, PMID 37510965, PMID 38545090, PMID 39393522